WASHINGTON and PARIS (PRWEB)
December 14, 2017
RJM GROUP, LLC based in Washington, D.C., and Aixial, headquartered in Paris, announced today they have formed a global alliance resulting in expanded capabilities in addressing the challenges of evaluating new technologies and the increasing demand for patient/clinical outcomes studies.
Gary Milkovich, Founding Partner of RJM says, “We are very excited about our alliance with Aixial and the opportunity to leverage resources and strengths, and to maximize current and future networks in providing specialized services and greater benefits to our clients.”
RJM Group, LLC., is a leading consultancy specializing in clinical outcomes and health economics. RJM Group’s unique capabilities and project success enables it to build a strong European Union and U.S. network of hospitals, physicians and physician groups, and hospital-based finance departments.
Emmanuel Riffault, Director of Aixial says, “We are definitely convinced about the synergies created by the alliance between the expertise in real-life studies and health economics of RJM Group and the teams of Aixial to bring more value and benefit to our European and US clients.”
Aixial is one of the largest and fastest growing Clinical Research Organizations (CRO) in Europe, and is currently expanding into Asia and the US. Aixial has in-depth and proven experience working with pharma, biotech, vaccines, medical devices, cosmetics, and nutraceutics.
About the Companies
RJM Group, LLC, is a cutting edge U.S. consulting company that provides detailed clinical outcomes and health economics information to pharmaceutical companies, institutions, and practitioners, serving the EU for two decades. Learn more at http://www.RJMGroupLLC.com
Aixial, (an Alten company) is a full-service…